1-anilino-8-naphthalenesulfonate has been researched along with Cystic Fibrosis of Pancreas in 228 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Excerpt | Relevance | Reference |
---|---|---|
"Fifteen patients with cystic fibrosis and pancreatic insufficiency were studied during four randomised seven day treatment periods in which they received only pancreatic supplement (Pancrelipase, 27 capsules per day) or supplement plus cimetidine (20 mg/kg body weight/24 h) or sodium bicarbonate (15 g/m2/24 h) alone or in combination." | 9.05 | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. ( Bell, L; Corey, ML; Durie, PR; Forstner, GG; Linton, W, 1980) |
"Measurements of breath 13CO2 do not consistently reflect the gastrointestinal handling of emulsified 13C labelled tripalmitin because of differences in digestion and absorption in cystic fibrosis." | 7.70 | Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. ( Jones, AE; Laiho, KM; Murphy, JL; Wootton, SA, 1998) |
"Interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha) concentrations were measured in faecal samples from nine patients with cystic fibrosis and nine healthy age matched controls." | 7.69 | Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis. ( Briars, GL; Dean, TP; Murphy, JL; Rolles, CJ; Warner, JO, 1995) |
"Serum immunoreactive pancreatic lipase and cationic trypsinogen are elevated in young infants with cystic fibrosis (CF) and may be useful neonatal screening tests for CF." | 7.67 | Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis. ( Benjamin, L; Cleghorn, G; Corey, M; Dati, F; Durie, P; Forstner, G, 1985) |
"Cimetidine was effective in reducing acid secretion in such patients and led to small improvements in fat absorption." | 6.65 | The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis. ( Cameron, DJ; Ghale, GK; Harries, JT; Matthew, DJ; Milla, PJ; More, J; Pitcher-Wilmott, R, 1982) |
"Fifteen patients with cystic fibrosis and pancreatic insufficiency were studied during four randomised seven day treatment periods in which they received only pancreatic supplement (Pancrelipase, 27 capsules per day) or supplement plus cimetidine (20 mg/kg body weight/24 h) or sodium bicarbonate (15 g/m2/24 h) alone or in combination." | 5.05 | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. ( Bell, L; Corey, ML; Durie, PR; Forstner, GG; Linton, W, 1980) |
"To evaluate the antibacterial and antibiofilm mechanisms of usnic acid (USN) against methicillin-resistant Staphylococcus aureus from cystic fibrosis patients." | 3.83 | Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus. ( Angelucci, S; Barone, L; Crocetta, V; Di Bonaventura, G; Di Giulio, A; Di Giuseppe, F; Di Ilio, C; Pompilio, A; Pomponio, S; Riviello, A; Sulpizio, M, 2016) |
"Measurements of breath 13CO2 do not consistently reflect the gastrointestinal handling of emulsified 13C labelled tripalmitin because of differences in digestion and absorption in cystic fibrosis." | 3.70 | Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. ( Jones, AE; Laiho, KM; Murphy, JL; Wootton, SA, 1998) |
"Interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha) concentrations were measured in faecal samples from nine patients with cystic fibrosis and nine healthy age matched controls." | 3.69 | Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis. ( Briars, GL; Dean, TP; Murphy, JL; Rolles, CJ; Warner, JO, 1995) |
" The slight increase in the ratio hw/hs of maleimide bound to membrane protein-SH groups of erythrocytes in cystic fibrosis may ensue the lowered membrane protein immobilization in the plane of lipid bilayer, especially at the intrinsic, more slowly reacting thiol groups." | 3.68 | Cystic fibrosis--V. Does cystic fibrosis alter the values of dynamic parameters of erythrocyte membrane ghosts? ( Jedrychowska, K; Piasecki, W; Watała, C; Witas, H, 1993) |
"Serum immunoreactive pancreatic lipase and cationic trypsinogen are elevated in young infants with cystic fibrosis (CF) and may be useful neonatal screening tests for CF." | 3.67 | Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis. ( Benjamin, L; Cleghorn, G; Corey, M; Dati, F; Durie, P; Forstner, G, 1985) |
"The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase." | 3.67 | Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. ( Brannon, PM; Hazlett, D; Korc, M, 1986) |
" Symptoms and adverse events were evaluated as secondary endpoints." | 2.82 | Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. ( Ahrens, RC; Forssmann, K; Graff, G; Heubi, JE; Jain, R; Schaeffer, D; Sollo, N; Strausbaugh, S; Witte, S, 2016) |
" PA bioavailability estimates for CF subjects without pancreatic enzyme administration (1." | 2.80 | Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency. ( Barrett, JS; Mascarenhas, MR; Mondick, J; Schall, JI; Stallings, VA; Wilson, M, 2015) |
" All of the patients were required to discontinue their long-term use of porcine PERTs at the time of enrollment." | 2.77 | Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis. ( Borowitz, D; Brettman, LR; Campion, M; Stevens, C; Thompson, H; Wilschanski, M, 2012) |
"Postprandial hyperglycemia is an important clinical problem in cystic fibrosis (CF), but the contribution of fat malabsorption, rapid gastric emptying, and the incretin axis has not been widely considered." | 2.76 | Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. ( Chapman, I; Greville, H; Hetzel, D; Horowitz, M; Jones, KL; Kuo, P; Maddox, A; Rayner, CK; Russo, A; Stevens, JE; Wishart, JM, 2011) |
" At the other dosing levels, the mean coefficient of fat and nitrogen absorption increases were 19." | 2.72 | Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. ( Ahrens, R; Aitken, ML; Borowitz, D; Dunitz, J; Goss, CH; Hayes, D; Hendeles, L; Konstan, MW; Mahl, TC; Moss, R; Murray, FT; Newman, L; O'Rourke, A; Oermann, CM; Orenstein, D; Stevens, C; Wagener, J; Young, KR, 2006) |
" No adverse events related to study drug were reported." | 2.71 | Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy. ( Colin, P; Duggan, C; Eigen, H; Konstan, MW; Sherman, JM; Stern, RC; Trout, JR; Wagener, JS; Wohl, ME, 2004) |
" A high-strength preparation is thought to release relatively less enzyme activity in the small intestine, forcing patients to increase their dosage and possibly creating a dangerous enzyme hyperconcentration in the large intestine." | 2.68 | High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial. ( Cabrini, G; Lancellotti, L; Mastella, G; Zanolla, L, 1996) |
" Steatorrhoea was assessed by 3 day faecal fat analysis and dosage of medication, stool frequency and consistency; abdominal pain and appetite were documented by a patient-kept diary card." | 2.67 | A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. ( Matthew, DJ; Milla, PJ; Vyas, H, 1990) |
"a double blind, crossover study of two pH sensitive microsphere preparations of pancreatin (Creon, Pancrease), given in equivalent lipase dosage to 27 children with cystic fibrosis, was conducted." | 2.67 | A comparison of two pancreatin microsphere preparations in cystic fibrosis. ( Akroyd, RM; Elliott, RB; Escobar, LC; Lees, HR; Reilly, HC, 1992) |
" Capsule dosage was adjusted to a ratio of approximately 3:1." | 2.67 | Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. ( Bowden, MW; Byers, CA; Dodge, JA; Guilford, SA; McCracken, KJ; Morrison, G; Morrison, JM; Redmond, AO, 1992) |
"Twenty-one stable hospitalized cystic fibrosis patients with malabsorption syndrome participated in an open-label crossover clinical trial to evaluate the efficacy of two-period dosing regimens of a pancreatic microtablet enzyme preparation in the treatment of steatorrhea." | 2.67 | Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis. ( Beker, LT; Chaney, HR; Evans, E; Fink, RJ; Kluft, J; Schidlow, DV; Shamsa, FH, 1994) |
"In an attempt to critically examine the therapeutic efficacy of pH-sensitive enteric-coated pancreatic enzyme preparations in patients with pancreatic insufficiency due to cystic fibrosis, postprandial duodenal concentration and recovery of orally administered pancreatic enzymes, duodenal pH, and coefficient of fat absorption were determined in eight cases after ingestion of equivalent dosage of enteric-coated as well as conventional enzyme preparations." | 2.66 | Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. ( Appler, M; Dutta, SK; Hubbard, VS, 1988) |
" With Pancrease, the number of daily dosage units is decreased even when fat intake is increased." | 2.66 | Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. ( Ansaldi-Balocco, N; Santini, B; Sarchi, C, 1988) |
"Cimetidine was effective in reducing acid secretion in such patients and led to small improvements in fat absorption." | 2.65 | The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis. ( Cameron, DJ; Ghale, GK; Harries, JT; Matthew, DJ; Milla, PJ; More, J; Pitcher-Wilmott, R, 1982) |
" The FDA recently required all manufacturers to submit New Drug Applications to continue to market these agents because published data demonstrated variation in formulation, bioavailability and shelf-life while providing limited data about efficacy and safety." | 2.45 | Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. ( Conwell, DL; Dimagno, MJ; Schoenfeld, PS; Waljee, AK; Wu, BU, 2009) |
"To establish the diagnosis of acute pancreatitis the estimation of amylase in serum and urine, lipase and radio-immunoreactive trypsin in the serum are useful." | 2.36 | [Examination of pancreatic function in children with special reference to the PABA-test (author's transl)]. ( Dockter, G; Sitzmann, FC, 1980) |
" The proposed method can be considered as a first approach for an evidence-based method in PERT dosing based on food characteristics." | 1.51 | Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis. ( Andrés, A; Boon, M; Bulfamante, A; Calvo-Lerma, J; Claes, I; Colombo, C; Crespo-Escobar, P; de Boeck, K; Fornés-Ferrer, V; Garriga, M; Hulst, J; Martínez-Barona, S; Masip, E; Ribes-Koninckx, C; Roca, M; Ruperto, M; van der Wiel, E; Woodcock, S, 2019) |
"Patients with cystic fibrosis have to take enzymatic supplements to allow for food digestion." | 1.51 | A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis. ( Andrés, A; Calvo-Lerma, J; Fornés-Ferrer, V; Heredia, A; Peinado, I; Ribes-Koninckx, C, 2019) |
"In this study population, no correlation between an enzyme dosage and the degree of fat malabsorption was found; however, a CFA below 85% was found in 24% of the measurements." | 1.42 | Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis. ( Houwen, RH; van der Ent, CK; Woestenenk, JW, 2015) |
"Patients attending US cystic fibrosis programs achieving highest nutritional outcomes, measured by mean BMI percentile, have higher enzyme dosing than those attending programs at lower performance levels." | 1.40 | Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis. ( Haupt, ME; Kwasny, MJ; McColley, SA; Schechter, MS, 2014) |
"The current recommendations for dosing of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) were made using a limited evidence base." | 1.39 | Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration. ( Borowitz, D; Gelfond, D; Heubi, JE; Maguiness, K; Ramsey, B, 2013) |
" There were no further serious suspected adverse drug reactions related to pancreatin 40,000 and no cases of fibrosing colonopathy." | 1.37 | A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis. ( Connett, GJ; Henniges, F; Littlewood, JM; Sander-Struckmeier, S, 2011) |
"Cystic fibrosis is associated with pancreatic insufficiency and acidic intraluminal conditions that limit the action of pancreatic enzyme replacement therapy, especially that of lipase." | 1.36 | Modification of pancreatic lipase properties by directed molecular evolution. ( Colin, DY; Deprez-Beauclair, P; Infantes, L; Kerfelec, B; Silva, N, 2010) |
"However, pancreatitis was also reported for 15 patients with PI from 11 centers in 9 different countries." | 1.33 | Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. ( De Boeck, K; Kerem, E; Proesmans, M; Weren, M, 2005) |
"Ursodiol, the drug of choice for the treatment of cystic fibrosis liver disease, may offer a safe method of using high-dose IBU in these patients by ameliorating the enteropathy." | 1.31 | Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat. ( Beno, DW; Jiyamapa-Serna, VA; Kimura, RE; Lloyd-Still, JD; Uhing, MR, 2001) |
"Children with cystic fibrosis have variable degrees of exocrine pancreatic insufficiency which, if untreated, is the main cause of fat malabsorption." | 1.30 | 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. ( Amarri, S; Coward, WA; Evans, TJ; Harding, M; Weaver, LT, 1997) |
" The following aspects of the patients' history were recorded (a) current type of pancreatic enzyme medication; (b) total dosage per day (with reference to lipase units); (c) duration of therapy with standard-strength pancreatic enzyme (SSPE) preparations (< or = 10,000 lipase units per capsule) and HSPE preparations (> or = 20,000 lipase units per capsule); (d) gastrointestinal complication (distal intestinal obstruction syndrome, meconium ileus, abdominal surgery, intussusception), diabetes mellitus, and hepatobiliary complications." | 1.30 | Ultrasound studies of the intestinal wall in patients with cystic fibrosis. ( Krackhardt, B; Lembcke, B; Pohl, M; Posselt, HG, 1997) |
"We retrospectively reviewed pancreatic enzyme dosing for 267 cystic fibrosis patients with pancreatic insufficiency." | 1.30 | Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. ( Chong, SK; Heilman, DK; Hollingsworth, J; Maguiness, KM; Stevens, JC, 1998) |
" Mean PES dosage was significantly decreased in 15 patients from 18,380 to 8647 units lipase/kg/day." | 1.30 | Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. ( Doull, IJ; Goodchild, MC; Lowdon, J; Ryley, HC, 1998) |
" There was no relationship between enzyme dosage and colon thickness but simple regression identified a significant relationship (P < 0." | 1.30 | Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis. ( Atchley, JT; Connett, GJ; Fairhurst, JJ; Lucas, JS; Rolles, CJ, 1999) |
" Patients with high dosage requirements could benefit from changing the pattern of their pancreatin supplementation." | 1.30 | Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis. ( Frier, M; Ghosal, S; Hillel, PG; Read, N; Senior, S; Taylor, CJ; Tindale, WB, 1999) |
"Excessive dosage of pancreatic enzymes in cystic fibrosis (CF) patients can be associated with irreversible colonic stricture." | 1.29 | Cystic fibrosis and colonic strictures. A new "iatrogenic" disease. ( Lloyd-Still, JD, 1995) |
"Biochemical vitamin E deficiency and low plasma lipids are frequent findings in patients with cystic fibrosis (CF)." | 1.29 | Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals. ( Molinari, L; Shmerling, DH; Tuchschmid, PE; Winklhofer-Roob, BM, 1996) |
"Pancreatic enzyme products are formulated, manufactured, and sold without submitting efficacy or bioavailability data to the Food and Drug Administration because of a quirk in the law." | 1.28 | Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. ( Dorf, A; Hendeles, L; Stecenko, A; Weinberger, M, 1990) |
"The uric acid excretion was lower than in the nocturnal period before the test." | 1.28 | Uric acid serum concentrations in CF-children after pancreatic enzyme supplementation. ( Ballke, EH; Paul, W; Wiersbitzky, S; Wolf, E, 1989) |
"Patients with cystic fibrosis have been found to have abnormal serum concentrations of immunoreactive trypsin and abnormal activities of pancreatic isoamylase." | 1.27 | Serum pancreatic lipase activity in cystic fibrosis. ( Batten, JC; Dandona, P; Hodson, ME; Junglee, D; Katrak, A; Penketh, A, 1983) |
" Based on the dissolution pH profiles of current enteric-coated pancreatic enzyme products, the duodenal postprandial pH in CF subjects may be too acidic to permit rapid dissolution of current enteric-coated dosage forms." | 1.27 | Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. ( Amidon, GL; Berardi, RR; Dressman, JB; Howatt, WF; Hyneck, ML; Meyer, JH; Youngberg, CA, 1987) |
"The article reports on a study to determine the influence of different dosage schedules of a pancreas enzyme preparation on the digestion of fat and protein and on the lipolytic, tryptic and chymotryptic activity of the faeces in children suffering from mucoviscidose." | 1.26 | [Digestion of fat and protein and its relation to the activity of faecal enzymes in mucoviscidosis infants under substitution therapy with pancreatic enzymes (author's transl)]. ( Kutschera, J; Lohmann, A; Tolckmitt, W, 1981) |
"Patients with pancreatic insufficiency have a ravenous appetite but fail to thrive from malnutrition." | 1.26 | [Exocrine pancreatic insufficiency (author's transl)]. ( Götze, H, 1980) |
"Two patients were diagnosed as having acute pancreatitis before the diagnosis of CF was made, thus indicating that acute pancreatitis may be the presenting complaint in the young adult with CF." | 1.25 | Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. ( Khaw, KT; Lebenthal, E; Shwachman, H, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 96 (42.11) | 18.7374 |
1990's | 82 (35.96) | 18.2507 |
2000's | 24 (10.53) | 29.6817 |
2010's | 23 (10.09) | 24.3611 |
2020's | 3 (1.32) | 2.80 |
Authors | Studies |
---|---|
Olsen, MF | 1 |
Kjøller-Svarre, MS | 1 |
Møller, G | 1 |
Katzenstein, TL | 1 |
Nielsen, BU | 1 |
Pressler, T | 1 |
Lewis, JI | 1 |
Mathiesen, IH | 1 |
Mølgaard, C | 1 |
Faurholt-Jepsen, D | 1 |
Ganesh, PS | 1 |
Vishnupriya, S | 1 |
Vadivelu, J | 1 |
Mariappan, V | 1 |
Vellasamy, KM | 1 |
Shankar, EM | 1 |
Sathe, MN | 1 |
Patel, D | 1 |
Stone, A | 1 |
First, E | 1 |
Freedman, S | 1 |
Orenstein, D | 2 |
Black, P | 1 |
Brown, P | 1 |
McCoy, K | 1 |
Stevens, J | 1 |
Grujic, D | 1 |
Clayton, R | 1 |
Wang, GL | 1 |
Zhao, CN | 1 |
Zhou, J | 1 |
Yu, FH | 1 |
Shen, HQ | 1 |
Zhang, J | 1 |
Zhao, SY | 1 |
Xu, XW | 1 |
Hill, PJ | 1 |
Scordo, JM | 1 |
Arcos, J | 1 |
Kirkby, SE | 1 |
Wewers, MD | 1 |
Wozniak, DJ | 1 |
Torrelles, JB | 1 |
Alkaade, S | 1 |
Vareedayah, AA | 1 |
Venuti, E | 1 |
Shishmarev, D | 1 |
Kuchel, PW | 2 |
Dutt, S | 1 |
Blumenthal, CS | 1 |
Gaskin, KJ | 4 |
Calvo-Lerma, J | 2 |
Fornés-Ferrer, V | 2 |
Peinado, I | 1 |
Heredia, A | 1 |
Ribes-Koninckx, C | 2 |
Andrés, A | 2 |
Hulst, J | 1 |
Boon, M | 1 |
Colombo, C | 1 |
Masip, E | 1 |
Ruperto, M | 1 |
van der Wiel, E | 1 |
Claes, I | 1 |
Garriga, M | 1 |
Roca, M | 1 |
Crespo-Escobar, P | 1 |
Bulfamante, A | 1 |
Woodcock, S | 1 |
Martínez-Barona, S | 1 |
de Boeck, K | 4 |
Borowitz, D | 6 |
Gelfond, D | 1 |
Maguiness, K | 1 |
Heubi, JE | 2 |
Ramsey, B | 1 |
Haupt, ME | 1 |
Kwasny, MJ | 1 |
Schechter, MS | 1 |
McColley, SA | 1 |
Declercq, D | 1 |
Van Biervliet, S | 1 |
Robberecht, E | 1 |
Mascarenhas, MR | 1 |
Mondick, J | 1 |
Barrett, JS | 1 |
Wilson, M | 1 |
Stallings, VA | 2 |
Schall, JI | 2 |
Woestenenk, JW | 1 |
van der Ent, CK | 1 |
Houwen, RH | 1 |
Loli, H | 1 |
Narwal, SK | 1 |
Saun, NK | 1 |
Gupta, R | 1 |
van der Haak, N | 1 |
Boase, J | 1 |
Davidson, G | 1 |
Butler, R | 1 |
Miller, M | 1 |
Kaambwa, B | 1 |
Kritas, S | 1 |
Schaeffer, D | 1 |
Ahrens, RC | 1 |
Sollo, N | 1 |
Strausbaugh, S | 1 |
Graff, G | 1 |
Jain, R | 1 |
Witte, S | 1 |
Forssmann, K | 1 |
Pompilio, A | 1 |
Riviello, A | 1 |
Crocetta, V | 1 |
Di Giuseppe, F | 1 |
Pomponio, S | 1 |
Sulpizio, M | 1 |
Di Ilio, C | 1 |
Angelucci, S | 1 |
Barone, L | 1 |
Di Giulio, A | 1 |
Di Bonaventura, G | 1 |
Herzog, DC | 1 |
Delvin, EE | 1 |
Albert, C | 1 |
Marcotte, JE | 1 |
Pelletier, VA | 1 |
Seidman, EG | 1 |
Waljee, AK | 1 |
Dimagno, MJ | 1 |
Wu, BU | 1 |
Schoenfeld, PS | 1 |
Conwell, DL | 1 |
Colin, DY | 1 |
Deprez-Beauclair, P | 1 |
Silva, N | 1 |
Infantes, L | 1 |
Kerfelec, B | 1 |
Littlewood, JM | 8 |
Connett, GJ | 3 |
Sander-Struckmeier, S | 1 |
Henniges, F | 1 |
Kuo, P | 1 |
Stevens, JE | 1 |
Russo, A | 1 |
Maddox, A | 1 |
Wishart, JM | 1 |
Jones, KL | 1 |
Greville, H | 1 |
Hetzel, D | 1 |
Chapman, I | 1 |
Horowitz, M | 1 |
Rayner, CK | 1 |
Wier, HA | 1 |
Kuhn, RJ | 1 |
Stevens, C | 3 |
Brettman, LR | 2 |
Campion, M | 2 |
Chatfield, B | 1 |
Cipolli, M | 1 |
Wilschanski, M | 2 |
Thompson, H | 1 |
Proesmans, M | 2 |
Virgilis, D | 1 |
Rivkin, L | 1 |
Samueloff, A | 1 |
Picard, E | 1 |
Goldberg, S | 1 |
Faber, J | 2 |
Kerem, E | 3 |
BACHMANN, KD | 1 |
WANG, DY | 1 |
SLACK, J | 1 |
NAIR, S | 1 |
TRAISMAN, H | 1 |
BECKER, G | 1 |
MAHLER, S | 1 |
HSIA, DY | 2 |
STEIGMANN, F | 1 |
SNYDER, D | 1 |
FERNANDEZ, A | 1 |
TURNER, EJ | 1 |
JAKOVCIC, S | 1 |
BRECKENRIDGE, RL | 1 |
LYNCH, PV | 1 |
ROSENBERG, IR | 1 |
JANOWITZ, HD | 1 |
SIGLER, RM | 1 |
REEVES, HH | 1 |
LYNN, HB | 1 |
BURKE, EC | 1 |
Symonds, EL | 1 |
Omari, TI | 1 |
Webster, JM | 1 |
Davidson, GP | 2 |
Butler, RN | 1 |
Armand, M | 1 |
Hamosh, M | 1 |
Philpott, JR | 1 |
Resnik, AK | 1 |
Rosenstein, BJ | 3 |
Hamosh, A | 1 |
Perman, JA | 1 |
Hamosh, P | 1 |
Walkowiak, J | 2 |
Nousia-Arvanitakis, S | 1 |
Lisowska, A | 2 |
Piotrowski, R | 1 |
Strzykala, K | 1 |
Bychowiec, B | 1 |
Songin, T | 1 |
Galli-Tsinopoulou, A | 1 |
Sands, D | 1 |
Pidonia, I | 1 |
Krawczynski, M | 2 |
Milanowski, A | 1 |
Herzig, KH | 2 |
Przyslawski, J | 1 |
Grzymislawski, M | 1 |
Mosler, K | 1 |
von Kries, R | 1 |
Vermeer, C | 1 |
Saupe, J | 1 |
Schmitz, T | 1 |
Schuster, A | 1 |
Konstan, MW | 3 |
Stern, RC | 1 |
Trout, JR | 1 |
Sherman, JM | 1 |
Eigen, H | 1 |
Wagener, JS | 1 |
Duggan, C | 1 |
Wohl, ME | 1 |
Colin, P | 1 |
Weren, M | 1 |
Kalnins, D | 1 |
Corey, M | 4 |
Ellis, L | 1 |
Durie, PR | 9 |
Pencharz, PB | 1 |
Monroe, L | 1 |
Nowicki, M | 1 |
Giles, H | 1 |
Ruiz, F | 1 |
Goss, CH | 2 |
Hayes, D | 1 |
Newman, L | 1 |
O'Rourke, A | 1 |
Wagener, J | 1 |
Moss, R | 1 |
Hendeles, L | 3 |
Ahrens, R | 1 |
Oermann, CM | 1 |
Aitken, ML | 1 |
Mahl, TC | 1 |
Young, KR | 1 |
Dunitz, J | 1 |
Murray, FT | 2 |
Limauro, S | 1 |
Blake, K | 1 |
Casey, S | 1 |
Quittner, AL | 1 |
Bentley, T | 1 |
Dalal, S | 1 |
Singh, PK | 1 |
Raghava, S | 1 |
Rawat, S | 1 |
Gupta, MN | 1 |
Ingomar, CJ | 1 |
Terslev, E | 1 |
Gow, R | 1 |
Bradbear, R | 1 |
Francis, P | 1 |
Shepherd, R | 1 |
Hammond, KB | 2 |
Ask, CG | 1 |
Watts, DC | 1 |
Niessen, KH | 1 |
Shaul, S | 1 |
Goldstein, R | 1 |
Levy, E | 1 |
Bronza, N | 1 |
Freier, S | 1 |
Dockter, G | 1 |
Sitzmann, FC | 1 |
Götze, H | 1 |
Longnecker, DS | 1 |
Piantino, P | 1 |
Garrone, C | 1 |
Gallo, V | 1 |
Pecchio, F | 1 |
Corno, F | 1 |
Bonardi, O | 1 |
Cattaneo, U | 1 |
Junglee, D | 1 |
Penketh, A | 1 |
Katrak, A | 1 |
Hodson, ME | 2 |
Batten, JC | 3 |
Dandona, P | 1 |
Forstner, G | 3 |
Gaskin, K | 1 |
Durie, P | 4 |
Weber, AM | 3 |
Roy, CC | 3 |
Langbaum, TS | 1 |
Lee, L | 1 |
Hill, R | 1 |
Forstner, GG | 5 |
Tolckmitt, W | 1 |
Lohmann, A | 1 |
Kutschera, J | 1 |
Mitchell, EA | 1 |
Quested, C | 1 |
Marks, RE | 1 |
Pinnock, RE | 1 |
Elliott, RB | 2 |
Cameron, DJ | 1 |
Pitcher-Wilmott, R | 1 |
Milla, PJ | 2 |
More, J | 1 |
Ghale, GK | 1 |
Matthew, DJ | 2 |
Harries, JT | 2 |
Fredrikzon, B | 2 |
Hernell, O | 1 |
Bläckberg, L | 2 |
Muller, DP | 2 |
Stafford, RJ | 1 |
Grand, RJ | 3 |
Hill, RE | 1 |
Adriaenssens, K | 1 |
Van Riel, L | 1 |
Warwick, WJ | 1 |
Budd, JR | 1 |
Mischler, EH | 1 |
Parrell, S | 1 |
Farrell, PM | 1 |
Odell, GB | 1 |
Roulet, M | 1 |
Paradis, Y | 1 |
Chartrand, L | 1 |
Lasalle, R | 2 |
Morin, CL | 2 |
Pivetta, OH | 1 |
Vaccaro, MI | 1 |
Maillie, AJ | 1 |
Boyle, BJ | 1 |
Long, WB | 1 |
Balistreri, WF | 1 |
Widzer, SJ | 1 |
Huang, N | 1 |
Bell, L | 1 |
Linton, W | 1 |
Corey, ML | 2 |
Smyth, RL | 2 |
Ashby, D | 1 |
O'Hea, U | 1 |
Burrows, E | 1 |
Lewis, P | 1 |
van Velzen, D | 3 |
Dodge, JA | 4 |
Croft, NM | 1 |
Marshall, TG | 1 |
Ferguson, A | 1 |
Oades, PJ | 2 |
Bush, A | 2 |
Ong, PS | 1 |
Brereton, RJ | 1 |
Burdge, GC | 1 |
Goodale, AJ | 1 |
Hill, CM | 1 |
Halford, PJ | 1 |
Lambert, EJ | 1 |
Postle, AD | 1 |
Rolles, CJ | 4 |
Mac Sweeney, EJ | 1 |
Buchdahl, R | 1 |
Rosenthal, M | 1 |
Jones, R | 1 |
Franklin, K | 1 |
Spicer, R | 1 |
Berry, J | 1 |
Lloyd-Still, JD | 3 |
Tomasik, P | 1 |
Tursi, JM | 2 |
Phair, PG | 2 |
Barnes, GL | 2 |
Pedroli, G | 1 |
Liechti-Gallati, S | 1 |
Mauri, S | 1 |
Birrer, P | 1 |
Kraemer, R | 1 |
Foletti-Jäggi, C | 1 |
Bianchetti, MG | 1 |
Briars, GL | 1 |
Dean, TP | 1 |
Murphy, JL | 2 |
Warner, JO | 1 |
Bowler, IM | 1 |
Wolfe, SP | 2 |
Owens, HM | 1 |
Sheldon, TA | 1 |
Walters, MP | 4 |
Shah, A | 1 |
Dinwiddie, R | 1 |
Madge, S | 1 |
Prescott, P | 1 |
Hudson, G | 1 |
Gan, KH | 1 |
Heijerman, HG | 1 |
Geus, WP | 1 |
Bakker, W | 1 |
Lamers, CB | 2 |
Macpherson, C | 1 |
Beker, LT | 1 |
Fink, RJ | 1 |
Shamsa, FH | 1 |
Chaney, HR | 1 |
Kluft, J | 1 |
Evans, E | 1 |
Schidlow, DV | 2 |
Smyth, AR | 1 |
Lloyd, DA | 1 |
Heaf, DP | 1 |
Taylor, CJ | 3 |
Pettei, MJ | 1 |
Leonidas, JC | 1 |
Levine, JJ | 1 |
Gorvoy, JD | 1 |
Jones, NL | 1 |
Hofley, PM | 1 |
Zylberberg, P | 1 |
Delchier, JC | 1 |
Kraisinger, M | 1 |
Hochhaus, G | 1 |
Stecenko, A | 2 |
Bowser, E | 1 |
Ramakrishna, J | 1 |
Henker, J | 2 |
Hoffmann, D | 1 |
Paul, D | 1 |
Hein, J | 1 |
Paditz, E | 1 |
Doull, I | 1 |
Langton-Hewer, S | 1 |
Winklhofer-Roob, BM | 2 |
Tuchschmid, PE | 2 |
Molinari, L | 1 |
Shmerling, DH | 4 |
Freiman, JP | 1 |
FitzSimmons, SC | 2 |
Kapadia, C | 1 |
Regele, S | 1 |
Münch, R | 2 |
Barbier, Y | 1 |
Stern, M | 1 |
Lancellotti, L | 1 |
Cabrini, G | 1 |
Zanolla, L | 1 |
Mastella, G | 1 |
Barraclough, M | 1 |
Ip, WF | 1 |
Bronsveld, I | 1 |
Kent, G | 1 |
Seal, S | 1 |
McClean, P | 1 |
Walters, M | 1 |
Harding, M | 2 |
Coward, W | 1 |
Reichard, KW | 1 |
Vinocur, CD | 2 |
Franco, M | 1 |
Crisci, KL | 2 |
Flick, JA | 1 |
Billmire, DF | 1 |
Weintraub, WH | 1 |
Gavin, J | 1 |
Ellis, J | 1 |
Dewar, AL | 1 |
Greenberg, SB | 1 |
Wolfson, BJ | 1 |
Geller, E | 1 |
Pawel, BR | 1 |
de Chadarévian, JP | 1 |
Franco, ME | 1 |
Burkhart, GA | 1 |
Hammerstrom, T | 1 |
Lowenfels, AB | 1 |
Amarri, S | 2 |
Coward, WA | 1 |
Evans, TJ | 1 |
Weaver, LT | 2 |
Lee, J | 1 |
Ip, W | 1 |
Pohl, M | 1 |
Krackhardt, B | 1 |
Posselt, HG | 1 |
Lembcke, B | 1 |
Swart, GR | 2 |
Baartman, EA | 1 |
Wattimena, JL | 1 |
Rietveld, T | 1 |
Overbeek, SE | 1 |
van den Berg, JW | 1 |
Stevens, JC | 1 |
Maguiness, KM | 1 |
Hollingsworth, J | 1 |
Heilman, DK | 1 |
Chong, SK | 1 |
Robinson, P | 1 |
Hasler, WL | 1 |
Collins, CE | 1 |
O'Loughlin, EV | 1 |
Henry, R | 1 |
Delbeke, I | 1 |
Eggermont, E | 1 |
Veereman-Wauters, G | 1 |
Ghoos, Y | 1 |
Moss, RL | 1 |
Musemeche, CA | 1 |
Feddersen, RM | 1 |
Brägger, CP | 1 |
Altorfer, J | 1 |
Hoppe, B | 1 |
Ammann, R | 1 |
Lowdon, J | 1 |
Goodchild, MC | 3 |
Ryley, HC | 1 |
Doull, IJ | 1 |
Tiran, B | 1 |
van't Hof, MA | 1 |
Antonelli, M | 1 |
Matrunola, M | 1 |
Tontini, A | 1 |
Diamanti, S | 1 |
Laiho, KM | 1 |
Jones, AE | 1 |
Wootton, SA | 1 |
Ramsden, WH | 1 |
Moya, EF | 1 |
Augarten, A | 2 |
Katznelson, D | 1 |
Dubenbaum, L | 1 |
Doolman, R | 2 |
Sela, BA | 2 |
Lusky, A | 1 |
Szeinberg, A | 2 |
Kerem, BS | 1 |
Paret, G | 1 |
Gazit, E | 1 |
Sack, J | 1 |
Yahav, Y | 2 |
Lewenza, S | 1 |
Conway, B | 1 |
Greenberg, EP | 1 |
Sokol, PA | 1 |
Heys, SJ | 1 |
Orton, SL | 1 |
Allison, DG | 1 |
Carrère, J | 3 |
Guy-Crotte, O | 1 |
Gaia, E | 1 |
Figarella, C | 2 |
Lucas, JS | 1 |
Atchley, JT | 1 |
Fairhurst, JJ | 1 |
Hillel, PG | 1 |
Ghosal, S | 1 |
Frier, M | 1 |
Senior, S | 1 |
Tindale, WB | 1 |
Read, N | 1 |
Wutzke, KD | 1 |
Radke, M | 1 |
Breuel, K | 1 |
Gurk, S | 1 |
Lafrenz, JD | 1 |
Heine, WE | 1 |
Feigelson, J | 1 |
Pécau, Y | 1 |
Poquet, M | 1 |
Terdjman, P | 1 |
Chazalette, JP | 3 |
Ferec, C | 1 |
Shmilovich, H | 1 |
Aviram, M | 1 |
Akons, H | 1 |
Ben Tur, L | 1 |
Blau, H | 1 |
Rivlin, J | 1 |
Nouri-Sorkhabi, MH | 1 |
Chapman, BE | 1 |
Gruca, MA | 1 |
Garagorri, JM | 1 |
Rodríguez, G | 1 |
Ros, L | 1 |
Sánchez, A | 1 |
Lark, RK | 1 |
Lester, GE | 1 |
Ontjes, DA | 1 |
Blackwood, AD | 1 |
Hollis, BW | 1 |
Hensler, MM | 1 |
Aris, RM | 1 |
Beno, DW | 1 |
Uhing, MR | 1 |
Jiyamapa-Serna, VA | 1 |
Kimura, RE | 1 |
Smalley, CA | 1 |
Addy, DP | 1 |
Anderson, CM | 3 |
Bardoń, A | 1 |
Nowakowska, A | 1 |
Bozkowa, K | 1 |
Hoff, GE | 1 |
Hølby, N | 1 |
McCollum, JP | 1 |
Waring, WW | 1 |
Roller, RJ | 1 |
Kern, F | 1 |
Shwachman, H | 1 |
Lebenthal, E | 1 |
Khaw, KT | 1 |
Holzel, A | 1 |
Perman, J | 1 |
Breslow, L | 1 |
Ingal, D | 1 |
Richter, T | 1 |
Müller, D | 1 |
Senger, H | 1 |
Beyreiss, K | 1 |
Morrison, G | 1 |
Morrison, JM | 1 |
Redmond, AO | 1 |
Byers, CA | 1 |
McCracken, KJ | 1 |
Guilford, SA | 1 |
Bowden, MW | 1 |
Escobar, LC | 1 |
Lees, HR | 1 |
Akroyd, RM | 1 |
Reilly, HC | 1 |
Balasubramanian, K | 2 |
Zentler-Munro, PL | 3 |
Northfield, TC | 3 |
Assoufi, BA | 1 |
Cornell, S | 1 |
Benoliel, D | 1 |
Owen, G | 1 |
Peters, TJ | 1 |
Dawson, S | 1 |
Jansen, JB | 1 |
Hafkenscheid, JC | 1 |
Jongerius, CM | 1 |
Vyas, H | 1 |
Murphy, MS | 1 |
Eastham, EJ | 1 |
Nelson, R | 1 |
Aynsley-Green, A | 1 |
Williams, J | 1 |
MacDonald, A | 1 |
Weller, PH | 1 |
Fields, J | 1 |
Pandov, H | 1 |
Dorf, A | 1 |
Weinberger, M | 1 |
Hazlett, D | 1 |
Korc, M | 1 |
Brannon, PM | 1 |
Kelleher, J | 1 |
Johnson, AW | 1 |
Robinson, PJ | 1 |
Olinsky, A | 1 |
Smith, AL | 1 |
Chitravanshi, SB | 1 |
Morrow, JD | 1 |
Leblond, FA | 1 |
Morisset, J | 1 |
LeBel, D | 1 |
Zempsky, WT | 1 |
Carroll, JA | 1 |
Oski, FA | 1 |
Wiersbitzky, S | 1 |
Ballke, EH | 1 |
Wolf, E | 1 |
Paul, W | 1 |
Dain, MP | 1 |
Castaigne, JP | 1 |
Ansaldi-Balocco, N | 1 |
Santini, B | 1 |
Sarchi, C | 1 |
George, DE | 1 |
Mangos, JA | 1 |
Wicker-Böckelmann, U | 1 |
Wingender, J | 1 |
Winkler, UK | 1 |
Dutta, SK | 1 |
Hubbard, VS | 1 |
Appler, M | 1 |
Moreau, H | 1 |
Sauniere, JF | 1 |
Gargouri, Y | 1 |
Pieroni, G | 1 |
Verger, R | 1 |
Sarles, H | 1 |
Zsíros, J | 1 |
Sólyom, E | 1 |
Lonon, MK | 1 |
Woods, DE | 1 |
Straus, DC | 1 |
Costantini, D | 1 |
Padoan, R | 1 |
Curcio, L | 1 |
Giunta, A | 1 |
Bouquet, J | 2 |
Sinaasappel, M | 2 |
Neijens, HJ | 2 |
Kopelman, HR | 2 |
Sereda, EV | 1 |
Barashneva, SM | 1 |
Khuseĭkhanova, O | 1 |
Sirota, AV | 1 |
Galabert, C | 1 |
Thouvenot, JP | 1 |
Youngberg, CA | 1 |
Berardi, RR | 1 |
Howatt, WF | 1 |
Hyneck, ML | 1 |
Amidon, GL | 1 |
Meyer, JH | 1 |
Dressman, JB | 1 |
Weizman, Z | 1 |
Vesely, SM | 1 |
Fine, DR | 1 |
Abman, SH | 1 |
Reardon, MC | 1 |
Accurso, FJ | 1 |
Sokol, RJ | 1 |
Rizzotti, P | 1 |
Dechecchi, C | 1 |
Zanchetta, M | 1 |
Zaninotto, M | 1 |
Plebani, M | 1 |
Burlina, A | 1 |
Cleghorn, G | 2 |
Benjamin, L | 2 |
Dati, F | 2 |
Gebhardt, DO | 1 |
Brock, DJ | 1 |
Näntö, V | 1 |
Eskola, JU | 1 |
Bollbach, R | 1 |
Becker, M | 1 |
Rotthauwe, HW | 1 |
Goncerzewicz, M | 1 |
Socha, J | 1 |
Waligóra, A | 1 |
Waligóra, Z | 1 |
Chobot-Maciejewska, H | 1 |
Piontek, E | 1 |
Poley, JR | 1 |
Knill-Jones, RP | 1 |
Batten, PJ | 1 |
Williams, R | 1 |
Sagaró, E | 1 |
Brown, GA | 1 |
Cruchley, PM | 1 |
Jukes, HR | 1 |
van Kruiningen, HJ | 1 |
Williams, CB | 1 |
Cotton, EK | 1 |
Solomons, CC | 1 |
Dubois, R | 1 |
Simar, J | 1 |
Louis-Leclercq, MP | 1 |
Farriaux, JP | 1 |
Lapey, A | 1 |
Kattwinkel, J | 1 |
Di Sant'Agnese, PA | 1 |
Laster, L | 1 |
Littman, A | 1 |
Hanscom, DH | 1 |
Deckert, T | 1 |
Kolendorf, K | 1 |
Persson, I | 1 |
Worning, H | 1 |
Rey, J | 2 |
Hermier, M | 1 |
Mathieu, M | 1 |
Fillat, M | 1 |
Gilly, R | 1 |
Cotte, J | 1 |
Ricour, C | 1 |
Hadorn, B | 1 |
Johansen, PG | 1 |
Sacrez, R | 1 |
Klein, F | 1 |
Hoffmann, B | 1 |
Lévy, JM | 1 |
Geisert, J | 1 |
Korn, R | 1 |
Paganoni, O | 1 |
Witas, H | 1 |
Watała, C | 1 |
Jedrychowska, K | 1 |
Piasecki, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A 90 Day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on Parenteral Nutrition[NCT03530852] | 32 participants (Anticipated) | Interventional | 2018-11-21 | Recruiting | |||
Study to Evaluate Safety, Tolerability and Fat Absorption Using a Novel Enteral Feeding In-line Digestive Enzyme Cartridge (RELIZORB) in Patients With Cystic Fibrosis Receiving Enteral Feeding[NCT02598128] | 34 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
A 90 Day Observational Study as an Extension to the Phase 3, Open Labeled, Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on PN[NCT05635747] | 32 participants (Anticipated) | Observational | 2022-09-29 | Enrolling by invitation | |||
Proton Pump Inhibitors (PPI) and Fat Absorption in Subjects With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)[NCT03551691] | Phase 2 | 19 participants (Actual) | Interventional | 2018-08-07 | Completed | ||
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis[NCT01710644] | Phase 1/Phase 2 | 35 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
A Single-Center Prospective Randomized Placebo Controlled Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis[NCT02706236] | Phase 2 | 0 participants (Actual) | Interventional | 2016-04-30 | Withdrawn (stopped due to no funding was awarded) | ||
The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients[NCT01753024] | 362 participants (Actual) | Observational [Patient Registry] | 2012-01-31 | Completed | |||
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Crossover Study to Evaluate the Effectiveness and Safety of PANCRECARB® MS-16 (Pancrelipase) in Reducing Steatorrhea in Children and Adults With Cystic Fibrosis[NCT00432861] | Phase 3 | 29 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism[NCT00881452] | Phase 3 | 182 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
Evaluation of Physiological Responses During the Use of Interactive Video Game and the Cardiopulmonary Exercise Test in Cystic Fibrosis and Healthy Individuals[NCT03229213] | 55 participants (Actual) | Observational | 2017-08-30 | Completed | |||
Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF[NCT00406536] | Phase 2 | 110 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
A Pilot Study Evaluating Single, High-dose Pharmacokinetics/Pharmacodynamics of Vitamin D3 in CF[NCT03734744] | 6 participants (Actual) | Interventional | 2019-06-17 | Terminated (stopped due to Clinical research currently on hold) | |||
Double-blind Randomized Study to Determine the Efficacy of Intramuscular Vitamin D3 Supplementation in Tropical Calcific Pancreatitis[NCT00956839] | Phase 4 | 40 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
AUC analysis of plasma fatty acid concentration for DHA + EPA baseline adjusted over 24-hours (NCT02598128)
Timeframe: Day 1 first intervention and Day 9 second intervention.
Intervention | ug*h/mL (Mean) |
---|---|
RELiZORB | 536.98 |
Control | 192.18 |
Effect of enteral nutrition on select activities of daily living. Patients judged the size of breakfast after overnight enteral tube feeding with the following choices: No breakfast; Small breakfast; Normal breakfast; Big breakfast; Other. (NCT02598128)
Timeframe: Period C: Single assessment on Day 19 or 20
Intervention | Participants (Count of Participants) | ||||
---|---|---|---|---|---|
No breakfast | Small breakfast | Normal breakfast | Big breakfast | Other | |
Clinical Treatment Practice and Relizorb: Period C: Days 12-20 | 11 | 14 | 6 | 0 | 1 |
1) Frequency and severity of adverse events; 2) Patients with at least one unanticipated adverse device effects (UADE) (NCT02598128)
Timeframe: 27 days
Intervention | Participants (Count of Participants) | ||||
---|---|---|---|---|---|
Patients With Adverse Events | Adverse Event by Severity (Mild) | Adverse Event by Severity (Moderate) | Adverse Event by Severity (Severe) | Patients With At Least One UADE | |
Clinical Treatment Practice + RELiZORB: Period C: Days 12-20 | 2 | 0 | 1 | 1 | 0 |
Clinical Treatment Practice: Period A: Days -7 to -1 | 4 | 2 | 2 | 0 | 0 |
Crossover Period B: Placebo | 6 | 6 | 0 | 0 | 0 |
Crossover Period B: RELiZORB | 1 | 1 | 0 | 0 | 0 |
Percentage of patients in each group with serum 25 hydroxy vitamin D >30 ng/ml (NCT00956839)
Timeframe: 6 months post intervention
Intervention | percentage of patients (Number) |
---|---|
IM Vitamin D3 3,00,000 Units | 85 |
IM Vitamin D3 6,00,000 Units | 29 |
Oral Vitamin D3 | 0 |
Serum total calcium (mg/dL) at time points 0, 1, 3 and 6 months (NCT00956839)
Timeframe: 0, 1, 3, 6 months post intervention
Intervention | mg/dL (Mean) | |||
---|---|---|---|---|
baseline | 1 month | 3 months | 6 months | |
IM Vitamin D3 3,00,000 Units | 9.20 | 9.28 | 9.40 | 9.40 |
IM Vitamin D3 6,00,000 Units | 9.56 | 9.52 | 9.44 | 9.40 |
Oral Vitamin D3 | 9.24 | 9.28 | 9.40 | 9.28 |
21 reviews available for 1-anilino-8-naphthalenesulfonate and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
Topics: Animals; Biofilms; Burkholderia cepacia; Burkholderia cepacia complex; Burkholderia Infections; Comm | 2020 |
A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Topics: Age Factors; Age of Onset; Cystic Fibrosis; Dietary Fats; Digestive System Surgical Procedures; Enzy | 2017 |
Lipases in Medicine: An Overview.
Topics: Alzheimer Disease; Animals; Atherosclerosis; Cystic Fibrosis; Humans; Lipase; Medicine; Neoplasms; O | 2015 |
Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis.
Topics: Amylases; Biological Availability; Cystic Fibrosis; Enzyme Therapy; Feces; Female; Humans; Lipase; M | 2009 |
Pancreatic enzyme supplementation.
Topics: Amylases; Cystic Fibrosis; Drug Approval; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficie | 2011 |
THE PANCREAS. IV.
Topics: Amylases; Anatomy; Aprotinin; Cystic Fibrosis; Hypothermia; Hypothermia, Induced; Iron; Lipase; Panc | 1965 |
[Diseases of the exocrine pancreas in infants and children. A review. 1. Organic pancreatic diseases].
Topics: Amino Acid Metabolism, Inborn Errors; Amylases; Child, Preschool; Cholecystokinin; Cystic Fibrosis; | 1980 |
[Examination of pancreatic function in children with special reference to the PABA-test (author's transl)].
Topics: 4-Aminobenzoic Acid; Acute Disease; Aminobenzoates; Amylases; Child; Child, Preschool; Chronic Disea | 1980 |
Disorders of lipid absorption.
Topics: Abetalipoproteinemia; Abnormalities, Multiple; Bile Acids and Salts; Bile Ducts; Celiac Disease; Chi | 1982 |
Hereditary disease of the exocrine pancreas.
Topics: Adolescent; Adult; alpha 1-Antitrypsin Deficiency; Child; Child, Preschool; Cystic Fibrosis; Exocrin | 1982 |
[The physiological and pathologic role of human gastric lipase].
Topics: Adult; Aging; Child; Cystic Fibrosis; Dietary Fats; Humans; Infant; Lipase; Lipolysis; Neoplasms; Pa | 1995 |
Colonic strictures in cystic fibrosis.
Topics: Colonic Diseases; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Intestinal Diseases; I | 1995 |
[Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
Topics: Adolescent; Adult; Antacids; Capsules; Child; Chronic Disease; Cystic Fibrosis; Enzymes, Immobilized | 1993 |
Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
Topics: Adolescent; Chemistry, Pharmaceutical; Child; Child, Preschool; Cystic Fibrosis; Exocrine Pancreatic | 1994 |
The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature.
Topics: Biopsy; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Female; Humans; Infant; I | 1997 |
Current management of cystic fibrosis.
Topics: Adolescent; Adult; Aerosols; Amylases; Bronchodilator Agents; Child; Child, Preschool; Cystic Fibros | 1976 |
Pancreatic enzyme replacement therapy.
Topics: Adult; Capsules; Celiac Disease; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; | 1989 |
Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future.
Topics: Body Constitution; Celiac Disease; Cystic Fibrosis; Forecasting; Humans; Lipase; Microspheres; Pancr | 1988 |
[Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Topics: Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Drug Evaluation; Fe | 1988 |
Chronic diarrhea in infants and children. I.
Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Diarrhe | 1973 |
Current concepts: pancreatic extracts.
Topics: Adolescent; Adult; Animals; Bicarbonates; Cattle; Celiac Disease; Child; Cystic Fibrosis; Dietary Fa | 1969 |
39 trials available for 1-anilino-8-naphthalenesulfonate and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Double- | 2017 |
Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Fatty Acids; Female; H | 2015 |
Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
Topics: Adolescent; Breath Tests; Child; Cystic Fibrosis; Dietary Fats; Drug Administration Schedule; Enzyme | 2016 |
Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
Topics: Adolescent; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Exocrine Pancreatic Ins | 2016 |
Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Topics: Adult; Blood Glucose; Cystic Fibrosis; Dietary Carbohydrates; Dietary Fats; Double-Blind Method; Fem | 2011 |
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
Topics: Adolescent; Adult; Amylases; Child; Cystic Fibrosis; Double-Blind Method; Enzyme Replacement Therapy | 2011 |
Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
Topics: Adolescent; Adult; Amylases; Child; Cystic Fibrosis; Drug Administration Schedule; Enzyme Replacemen | 2012 |
Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
Topics: Adolescent; Adult; Aged; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Exocrine P | 2004 |
Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis.
Topics: Adolescent; Amylases; Child; Child, Preschool; Cross-Over Studies; Cystic Fibrosis; Female; Gastroin | 2005 |
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.
Topics: Adolescent; Adult; Amylases; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Humans; Lip | 2006 |
Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.
Topics: Adolescent; Adult; Amylases; Analysis of Variance; Blood Glucose; Child; Cystic Fibrosis; Dose-Respo | 2006 |
Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
Topics: Adolescent; Antacids; Celiac Disease; Child; Cimetidine; Clinical Trials as Topic; Cystic Fibrosis; | 1981 |
The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cimetidine; Cystic Fibrosis; Double-Blind Method; Gastric Acid; | 1982 |
Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Lipase; Malabsorption | 1982 |
Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
Topics: Adolescent; Adult; Bile Acids and Salts; Celiac Disease; Cimetidine; Cystic Fibrosis; Diet; Drug Com | 1980 |
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
Topics: Adolescent; Bicarbonates; Celiac Disease; Child; Cimetidine; Cystic Fibrosis; Dietary Fats; Drug The | 1980 |
A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.
Topics: Adolescent; Amylases; Bromelains; Capsules; Child; Child, Preschool; Cystic Fibrosis; Double-Blind M | 1993 |
High dose Nutrizym 22 in cystic fibrosis.
Topics: Adolescent; Amylases; Analysis of Variance; Bromelains; Child; Cystic Fibrosis; Double-Blind Method; | 1993 |
Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Topics: Adult; Cystic Fibrosis; Feces; Female; Humans; Lipase; Lipid Metabolism; Male; Middle Aged; Nitrogen | 1994 |
Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis.
Topics: Absorption; Adolescent; Adult; Body Weight; Celiac Disease; Child; Child, Preschool; Cross-Over Stud | 1994 |
Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
Topics: Adolescent; Adult; Child; Child, Preschool; Chymotrypsin; Cystic Fibrosis; Double-Blind Method; Exoc | 1996 |
High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
Topics: Adolescent; Adult; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Ins | 1996 |
Lipid digestion in cystic fibrosis: comparison of conventional and high-lipase enzyme therapy using the mixed-triglyceride breath test.
Topics: Adolescent; Breath Tests; Caprylates; Carbon Isotopes; Child; Cystic Fibrosis; Dietary Fats; Digesti | 1998 |
Colonic changes in cystic fibrosis: clinical-ultrasonographic features and their value for treatment.
Topics: Adolescent; Adult; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Dose-Response | 1998 |
Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Colon; Cystic Fibrosis; Female; Humans; I | 1998 |
Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Child; Child, Preschool; Cystic Fibrosis; Dose-Respons | 1992 |
A comparison of two pancreatin microsphere preparations in cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Double-Blind Method; Energy Inta | 1992 |
Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
Topics: Acids; Adult; Aspergillus niger; Celiac Disease; Cystic Fibrosis; Dietary Fats; Fungal Proteins; Hum | 1992 |
A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
Topics: Adolescent; Amylases; Analysis of Variance; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis | 1990 |
Two enteric coated microspheres in cystic fibrosis.
Topics: Adolescent; Body Weight; Capsules; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Exocrine | 1990 |
In vivo and in vitro studies of microsphere pancreatic supplements.
Topics: Adolescent; Adult; Albumins; Amylases; Bile Acids and Salts; Biological Availability; Child; Cystic | 1988 |
High compared with standard dose lipase pancreatic supplement.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Delayed-Action Prepa | 1989 |
Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
Topics: Adolescent; Biological Availability; Celiac Disease; Child; Clinical Trials as Topic; Cystic Fibrosi | 1988 |
Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Topics: Adolescent; Age Factors; Celiac Disease; Child; Child, Preschool; Cimetidine; Clinical Trials as Top | 1988 |
Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Topics: Adult; Cystic Fibrosis; Delayed-Action Preparations; Drug Evaluation; Duodenum; Exocrine Pancreatic | 1988 |
[Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Topics: Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Drug Evaluation; Fe | 1988 |
Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
Topics: Adolescent; Adult; Bile Acids and Salts; Celiac Disease; Chemical Precipitation; Cimetidine; Cystic | 1985 |
[Comparative double blind experience of a polyenzymatic preparation in chronic pancreatic insufficiency (author's transl)].
Topics: Adolescent; Adult; Amylases; Bromelains; Celiac Disease; Chronic Disease; Clinical Trials as Topic; | 1973 |
Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.
Topics: Adolescent; Amylases; Bromelains; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis | 1974 |
169 other studies available for 1-anilino-8-naphthalenesulfonate and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Topics: Adult; Cross-Sectional Studies; Cystic Fibrosis; Enzyme Replacement Therapy; Exocrine Pancreatic Ins | 2022 |
Evaluation of the Effectiveness of In-line Immobilized Lipase Cartridge in Enterally Fed Patients With Cystic Fibrosis.
Topics: Adolescent; Adult; Body Weight; Child; Child, Preschool; Cystic Fibrosis; Enteral Nutrition; Humans; | 2021 |
[Clinical analysis of 11 children with pancreatic cystic fibrosis].
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Diarrhea; Female; Genetic Testing; Humans; Inf | 2017 |
Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.
Topics: Adolescent; Adult; Biofilms; Bronchoalveolar Lavage Fluid; Cell Wall; Child; Cystic Fibrosis; Female | 2017 |
Bile salt stimulated lipase: Inhibition by phospholipids and relief by phospholipase A
Topics: Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Insufficiency; Humans; Lipase; Magnetic Resonance | 2017 |
A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis.
Topics: Computer Simulation; Cystic Fibrosis; Digestion; Enzyme Replacement Therapy; Evidence-Based Medicine | 2019 |
Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.
Topics: Adolescent; Age Factors; Body Mass Index; Child; Cystic Fibrosis; Diet; Dietary Fats; Enzyme Replace | 2019 |
Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.
Topics: Cystic Fibrosis; Enzyme Replacement Therapy; Humans; Infant; Infant Nutritional Physiological Phenom | 2013 |
Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; | 2014 |
Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome.
Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Eat | 2015 |
Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Cystic Fibrosis; Diet Records; Enzyme | 2015 |
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Benzofurans; Biofilms; Carrier Prote | 2016 |
13C-labeled mixed triglyceride breath test (13C MTG-BT) in healthy children and children with cystic fibrosis (CF) under pancreatic enzyme replacement therapy (PERT): a pilot study.
Topics: Adolescent; Breath Tests; Child; Cystic Fibrosis; Female; Humans; Lipase; Male; Pancreas; Pilot Proj | 2008 |
Modification of pancreatic lipase properties by directed molecular evolution.
Topics: Amino Acid Substitution; Base Sequence; Cystic Fibrosis; Directed Molecular Evolution; DNA Primers; | 2010 |
New drug information: Zenpep.
Topics: Amylases; Animals; Cystic Fibrosis; Lipase; Pancreas; Peptide Hydrolases; Swine | 2010 |
A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
Topics: Adolescent; Adult; Body Weight; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Ga | 2011 |
Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: is there a link with gastrointestinal complaints?
Topics: Adolescent; Adult; Belgium; Child; Child, Preschool; Constipation; Cystic Fibrosis; Diet Surveys; Di | 2002 |
Cystic fibrosis, pregnancy, and recurrent, acute pancreatitis.
Topics: Acute Disease; Adult; Amylases; Cesarean Section; Cystic Fibrosis; Female; Gestational Age; Humans; | 2003 |
[On indirect evaluation of lipase activity by oral administration of iodized oil].
Topics: Administration, Oral; Cystic Fibrosis; Humans; Iodized Oil; Lipase | 1960 |
Lipoprotein lipase in cystic fibrosis of the pancreas.
Topics: Cystic Fibrosis; Humans; Lipase; Lipoprotein Lipase; Lipoproteins | 1962 |
Pancreatic enzyme replacement therapy in malabsorption of pancreatic, hepatic, and gastric origin.
Topics: Celiac Disease; Cystic Fibrosis; Disease; Enzyme Replacement Therapy; Enzyme Therapy; Enzymes; Gallb | 1962 |
Symptomatic treatment of mucoviscidosis with IMP 39.
Topics: Amylases; Cystic Fibrosis; Humans; Inosine Monophosphate; Lipase; Trypsin | 1962 |
Studies on mechanism for decreased lipoprotein lipase in cystic fibrosis of the pancrease.
Topics: Cystic Fibrosis; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Pancrelipase | 1963 |
LABORATORY DIAGNOSIS OF PANCREATIC DISEASE.
Topics: Amylases; Clinical Enzyme Tests; Cystic Fibrosis; Disease; Feces; Humans; Intubation; Intubation, Ga | 1964 |
CYSTIC FIBROSIS WITH FECAL RETENTION (MECONIUM ILEUS EQUIVALENT): REPORT OF TWO CASES.
Topics: Adolescent; Child; Cystic Fibrosis; Diagnosis; Diet; Diet Therapy; Drug Therapy; Feces; Humans; Ileu | 1965 |
Relation between pancreatic lipase activity and gastric emptying rate in children with cystic fibrosis.
Topics: Adolescent; Breath Tests; Caprylates; Child; Cystic Fibrosis; Dietary Fats; Digestion; Female; Gastr | 2003 |
Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion.
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Diet; Fats; Female; Gastric Emptying; Humans; | 2004 |
Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Cystic Fibrosis; Exocrine Pancreatic Ins | 2004 |
Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis.
Topics: Adolescent; Adult; Case-Control Studies; Child; Cystic Fibrosis; Feces; Female; Humans; Lipase; Male | 2004 |
Assessment of vitamin K deficiency in CF--how much sophistication is useful?
Topics: Adolescent; Adult; Apolipoproteins E; Biomarkers; Bone Diseases, Metabolic; Case-Control Studies; Ch | 2003 |
Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
Topics: Adult; Amylases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Panc | 2005 |
Clinical quiz. Diagnosis: fibrosing colonopathy.
Topics: Barium Sulfate; Colon; Constriction, Pathologic; Contrast Media; Cystic Fibrosis; Dose-Response Rela | 2006 |
Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.
Topics: Anthropometry; Child; Cystic Fibrosis; Dietary Fats; Energy Intake; Exocrine Pancreatic Insufficienc | 2006 |
Purification and properties of the alkaline lipase from Burkholderia cepacia A.T.C.C. 25609.
Topics: Base Sequence; Burkholderia cepacia; Circular Dichroism; Cystic Fibrosis; Detergents; Electrophoresi | 2008 |
Chronic diarrhoeas in infancy and childhood. II. Enzyme content of duodenal juice.
Topics: Amylases; Celiac Disease; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Diarrhea; Diarr | 1967 |
Immunoreactive pancreatic lipase test for neonatal detection of cystic fibrosis.
Topics: Clinical Enzyme Tests; Cystic Fibrosis; Humans; Infant, Newborn; Lipase; Pancreas | 1984 |
Serum lipase and trypsin in neonatal detection of cystic fibrosis.
Topics: Age Factors; Clinical Enzyme Tests; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Lipase; Trypsi | 1984 |
[The duodenal contents during digestion of a standard meal in cystic fibrosis].
Topics: Amylases; Child; Cystic Fibrosis; Digestion; Duodenum; Food; Humans; Hydrogen-Ion Concentration; Int | 1980 |
[Exocrine pancreatic insufficiency (author's transl)].
Topics: Amino Acid Metabolism, Inborn Errors; Amylases; Cystic Fibrosis; Enteropeptidase; Enzyme Therapy; Ex | 1980 |
Pathology and pathogenesis of diseases of the pancreas.
Topics: Acute Disease; Adenoma, Islet Cell; Amylases; Ascitic Fluid; Chronic Disease; Cystic Fibrosis; Diabe | 1982 |
[Immunotrypsinogen and amylase isoenzymes in pancreatic diseases].
Topics: Adolescent; Amylases; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Humans; Infant; Iso | 1983 |
Serum pancreatic lipase activity in cystic fibrosis.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Humans; Lipase; Pancreas; Trypsin | 1983 |
Pancreatic lipase, colipase, and cystic fibrosis.
Topics: Colipases; Cystic Fibrosis; Humans; Lipase; Pancreas; Proteins | 1984 |
Intraduodenal events in cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Cystic Fibrosis; Digestion; Duodenum; Humans; Hydrogen-Ion Concent | 1984 |
Lingual lipase activity in cystic fibrosis.
Topics: Adult; Animals; Cattle; Celiac Disease; Cystic Fibrosis; Dietary Fats; Digestion; Duodenum; Gastric | 1984 |
Incidence of distal intestinal obstruction syndrome in cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Humans; Intestinal Obstruction; Lipase; Pancreatic Extracts; Pan | 1983 |
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.
Topics: Adolescent; Adult; Celiac Disease; Child; Child, Preschool; Colipases; Cystic Fibrosis; Exocrine Pan | 1984 |
[Digestion of fat and protein and its relation to the activity of faecal enzymes in mucoviscidosis infants under substitution therapy with pancreatic enzymes (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Dietary Proteins; Feces; Humans; | 1981 |
Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
Topics: Celiac Disease; Child; Cystic Fibrosis; Female; Humans; Lipase; Male; Pancreatic Extracts; Pancreati | 1982 |
Lingual lipase. Its role in lipid digestion in infants with low birthweight and/or pancreatic insufficiency.
Topics: Bile Acids and Salts; Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Insufficiency; Humans; Infa | 1982 |
Steatorrhea and pancreatic insufficiency in Shwachman syndrome.
Topics: Adolescent; Aging; Agranulocytosis; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; Dietar | 1982 |
Serum pancreatic lipase as a screening test for cystic fibrosis.
Topics: Cystic Fibrosis; Humans; Infant; Infant, Newborn; Lipase; Mass Screening; Pancreas; Trypsin | 1982 |
Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
Topics: Adolescent; Cystic Fibrosis; Diet; Feces; Female; Humans; Lipase; Male; Pancreatic Extracts; Pancrel | 1982 |
Gastric emptying and lingual lipase activity in cystic fibrosis.
Topics: Adolescent; Butter; Cystic Fibrosis; Gastric Emptying; Gastric Juice; Glycerides; Humans; Lipase; Li | 1980 |
Lingual lipase: an important lipase in the digestion of dietary lipids in cystic fibrosis?
Topics: Adult; Animals; Biological Assay; Child; Cystic Fibrosis; Dietary Fats; Duodenum; Gastric Mucosa; Hu | 1980 |
Decreased lipase activity in pure pancreatic juice and duodenal content from mutant mice with some alterations resembling cystic fibrosis.
Topics: Animals; Cystic Fibrosis; Disease Models, Animal; Duodenum; Feces; Female; Genotype; Lipase; Male; M | 1981 |
Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
Topics: Adolescent; Amylases; Bromelains; Case-Control Studies; Cathartics; Child; Child, Preschool; Cohort | 1995 |
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements.
Topics: Adolescent; Albumins; alpha 1-Antitrypsin; Amylases; Bromelains; Case-Control Studies; Child; Child, | 1995 |
High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.
Topics: Amylases; Bromelains; Cecum; Child, Preschool; Colon; Constriction, Pathologic; Cystic Fibrosis; Dru | 1994 |
Plasma lipid concentrations in children with cystic fibrosis: the value of a high-fat diet and pancreatic supplementation.
Topics: Adolescent; Adult; Amylases; Child; Child, Preschool; Cholesterol; Chromatography, High Pressure Liq | 1994 |
Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis.
Topics: Adolescent; Adult; Amylases; Child; Child, Preschool; Colon; Cystic Fibrosis; Endopeptidases; Fibros | 1995 |
Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
Topics: Alginates; Aluminum Hydroxide; Amylases; Antacids; Anti-Ulcer Agents; Bromelains; Cisapride; Colon; | 1995 |
Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
Topics: Amylases; Animals; Bromelains; Colon; Colonic Diseases; Cystic Fibrosis; Drug Combinations; Fibrosis | 1995 |
Cystic fibrosis and colonic strictures. A new "iatrogenic" disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Colonic Diseases; Cystic Fibrosis; Humans; Iatrogenic Di | 1995 |
Plant sources of acid stable lipases.
Topics: Cystic Fibrosis; Duodenum; Humans; Hydrogen-Ion Concentration; Lipase; Plant Extracts | 1995 |
Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis.
Topics: Acidosis, Respiratory; Adolescent; Age Factors; Alkalosis; Body Weight; Case-Control Studies; Child; | 1995 |
Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis.
Topics: Adolescent; Adult; Biomarkers; Child; Cystic Fibrosis; Feces; Humans; Interleukin-8; Lipase; Lung; P | 1995 |
[Gene transfer in the gallbladder].
Topics: Adenoviruses, Human; Animals; Cell Line; Cystic Fibrosis; DNA, Complementary; Gallbladder; Gene Expr | 1995 |
Plant sources of acid stable lipases: potential therapy for cystic fibrosis.
Topics: Chromatography, Thin Layer; Cystic Fibrosis; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Conc | 1994 |
Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Colon; Colonic Diseases; Constriction, Patholog | 1994 |
Colonic strictures in cystic fibrosis.
Topics: Colonic Diseases; Constriction, Pathologic; Cystic Fibrosis; Humans; Intestinal Obstruction; Lipase; | 1994 |
Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
Topics: Child, Preschool; Chronic Disease; Chylous Ascites; Colon; Colonic Diseases; Cystic Fibrosis; Diarrh | 1994 |
Pathophysiology of the pancreatic defect in Johanson-Blizzard syndrome: a disorder of acinar development.
Topics: Case-Control Studies; Colipases; Consanguinity; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; | 1994 |
Gene therapy for exocrine pancreatic insufficiency.
Topics: Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Gallbladder; Genetic Therapy; Humans; Lipase; Pa | 1994 |
[Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
Topics: Adolescent; Capsules; Child; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; Humans; L | 1993 |
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation.
Topics: Amylases; Bromelains; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Humans; Inflammat | 1996 |
Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
Topics: Absorption; Administration, Oral; Adult; alpha-Tocopherol; Antioxidants; Biological Transport; Child | 1996 |
Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; | 1996 |
Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
Topics: Amylases; Case-Control Studies; Colon; Colonic Diseases; Cystic Fibrosis; Endopeptidases; Fibrosis; | 1996 |
Pancreatin preparations used in the treatment of cystic fibrosis--lipase content and in vitro release.
Topics: Bile Acids and Salts; Body Fluids; Buffers; Cystic Fibrosis; Duodenum; Gastrointestinal Agents; Hydr | 1996 |
Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption.
Topics: Absorption; Acids; Child; Child, Preschool; Circadian Rhythm; Cystic Fibrosis; Dietary Fats; Duodenu | 1996 |
Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice.
Topics: Amylases; Animals; Animals, Suckling; Chymotrypsin; Cystic Fibrosis; Diet; Lipase; Longevity; Mice; | 1996 |
Fibrosing colonopathy in children with cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Colon; Cystic Fibrosis; Female; Fibrosis; Humans; Infant; Infan | 1996 |
Stable isotope studies of pancreatic enzyme release in vivo.
Topics: Breath Tests; Carbon Isotopes; Child; Colon; Cystic Fibrosis; Female; Gastrointestinal Transit; Huma | 1996 |
Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.
Topics: Child; Child, Preschool; Clinical Protocols; Cystic Fibrosis; Follow-Up Studies; Humans; Infant; Lip | 1996 |
Fibrosing colonopathy in children with cystic fibrosis.
Topics: Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Female; Fibrosis; Humans; Infant; | 1997 |
Dietary fibre and the occurrence of gut symptoms in cystic fibrosis.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Cystic Fibrosis; Diet Records; Dietary Fiber; H | 1997 |
Contrast enema findings of fibrosing colonopathy.
Topics: Barium Sulfate; Child, Preschool; Colonic Diseases; Contrast Media; Cystic Fibrosis; Enema; Female; | 1997 |
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
Topics: Case-Control Studies; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Dose-Respon | 1997 |
13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.
Topics: Breath Tests; Carbon Isotopes; Child; Cystic Fibrosis; Female; Humans; Lipase; Male; Pancreatic Extr | 1997 |
Is fibrosing colonopathy an immune mediated disease?
Topics: Animals; Child; Child, Preschool; Colon; Cystic Fibrosis; Drug Administration Schedule; Female; Fibr | 1997 |
Ultrasound studies of the intestinal wall in patients with cystic fibrosis.
Topics: Adolescent; Cecum; Child; Colon; Cystic Fibrosis; Female; Humans; Ileum; Intestines; Lipase; Male; P | 1997 |
Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency.
Topics: Adult; Breath Tests; Calorimetry, Indirect; Carbon Dioxide; Carbon Isotopes; Case-Control Studies; C | 1997 |
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Topics: Adolescent; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Exocrine Pancreatic I | 1998 |
Fat gram target.
Topics: Cystic Fibrosis; Dietary Fats; Humans; Lipase; Pancreatic Extracts; Pancrelipase | 1997 |
Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-control study.
Topics: Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Humans; Infant; Intestinal Obstructi | 1998 |
Discrepancies between males and females with cystic fibrosis in dietary intake and pancreatic enzyme use.
Topics: Adolescent; Child; Cross-Sectional Studies; Cystic Fibrosis; Diet; Dietary Fats; Energy Intake; Fema | 1998 |
Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.
Topics: Child; Colon; Constriction, Pathologic; Cystic Fibrosis; Disease Progression; Fibrosis; Humans; Inte | 1998 |
Faecal immunoreactive lipase: a simple diagnostic test for cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Feces; Female; Humans; Infant; Infant, Newborn | 1998 |
Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation.
Topics: Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Feces; Follow-Up Studies; Gr | 1998 |
Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Cystic Fi | 1998 |
Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
Topics: Adolescent; Adult; Aging; Bile Acids and Salts; Child; Child, Preschool; Cystic Fibrosis; Dietary Ca | 1998 |
Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis.
Topics: Breath Tests; Carbon Isotopes; Child; Child, Preschool; Cystic Fibrosis; Digestive System; Feces; Fe | 1998 |
Serum lipase levels pre and post Lundh meal: evaluation of exocrine pancreatic status in cystic fibrosis.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Dietary Fats; Humans; Lipase; Pancreas; Pancreatic Diseas | 1998 |
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Burkholderia cepacia; Cloning, Molecular; Cy | 1999 |
Effect of urokinase on the extracellular virulence properties of Pseudomonas aeruginosa and Burkholderia cepacia.
Topics: Burkholderia cepacia; Culture Media; Cystic Fibrosis; Endopeptidases; Humans; Iron; Lipase; Oxygen; | 1999 |
Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Topics: Adolescent; Adult; Calcium-Binding Proteins; Child; Child, Preschool; Chromatography, Gel; Chymotryp | 1999 |
13C mixed triglyceride breath test.
Topics: Adult; Age Factors; Breath Tests; Carbon Dioxide; Carbon Isotopes; Celiac Disease; Child; Cystic Fib | 1998 |
Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Colon; Colonic Diseases; Constriction, Pathologic; | 1999 |
Fecal immunoreactive lipase, a simple diagnostic test for cystic fibrosis.
Topics: Authorship; Cystic Fibrosis; Feces; Humans; Infant; Infant, Newborn; Lipase | 1999 |
Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.
Topics: Adolescent; Adult; Breath Tests; Child; Child, Preschool; Cystic Fibrosis; Gastric Emptying; Gastroi | 1999 |
Triglyceride oxidation in cystic fibrosis: a comparison between different 13C-labeled tracer substances.
Topics: Adolescent; Breath Tests; Carbon Dioxide; Carbon Isotopes; Child; Cystic Fibrosis; Diet; Female; Foo | 1999 |
Fibrosing colonopathy.
Topics: Colon; Crohn Disease; Cystic Fibrosis; Diet; Dietary Fiber; Fibrosis; Humans; Lipase | 2000 |
Imaging changes in the pancreas in cystic fibrosis: a retrospective evaluation of 55 cases seen over a period of 9 years.
Topics: Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Diagnostic Imaging; Female; Humans; Lip | 2000 |
Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.
Topics: Adult; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocr | 2000 |
Parallel secretion of pancreatic phospholipase A(2), phospholipase A(1), lipase, and colipase in children with exocrine pancreatic dysfunction.
Topics: Adolescent; Child; Child, Preschool; Colipases; Cystic Fibrosis; Dietary Fats; Humans; Infant; Intes | 2000 |
Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Female; Glucose; | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Cholagogues and Choleretics; Cyst | 2001 |
Does that child really have cystic fibrosis?
Topics: Amylases; Bicarbonates; Child; Child, Preschool; Chlorides; Cholecystokinin; Cystic Fibrosis; Evalua | 1978 |
[Determination of the ribonuclease activity of the duodenal contents of children as a test in the differential diagnosis of cystic fibrosis and pancreatic exocrine insufficiency].
Topics: Amylases; Child; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Duodenum; Exocrine Panc | 1979 |
Staphylococcus aureus in cystic fibrosis: antibiotic sensitivity and phage types during the latest decade. Investigation of the occurrence of protein A and some other properties of recently isolated strains in relation to the occurrence of precipitating a
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Proteins; Bacteriophage Typing; Chemical Pre | 1975 |
Test meal for assessing intraluminal phase of absorption in childhood.
Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Cystic Fibrosis; Diet; Esterases; Female; | 1977 |
Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency.
Topics: Adult; Aged; Bile Acids and Salts; Breath Tests; Carbon Dioxide; Celiac Disease; Cystic Fibrosis; Di | 1977 |
Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes.
Topics: Acute Disease; Adolescent; Adult; Amylases; Chlorides; Cholecystokinin; Chymotrypsin; Cystic Fibrosi | 1975 |
Cystic fibrosis.
Topics: Adolescent; Adult; Animals; Carbenicillin; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; | 1975 |
Nonoperative treatment of meconium ileus equivalent.
Topics: Acetylcysteine; Child; Cystic Fibrosis; Enema; Feces; Female; Humans; Intestinal Obstruction; Lipase | 1975 |
[Determination of exocrine pancreatic function in childhood with the pancreozymin-secretin test].
Topics: Amylases; Child; Child, Preschool; Cholecystokinin; Cystic Fibrosis; Diagnosis, Differential; Exocri | 1992 |
Increased intragastric acid-resistant lipase activity and lipolysis in pancreatic steatorrhoea due to cystic fibrosis.
Topics: Adult; Animals; Celiac Disease; Cystic Fibrosis; Female; Gastric Acid; Humans; Hydrogen-Ion Concentr | 1992 |
Pancreatic enzyme supplement dosage in cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cystic Fibrosis; Food, Fortified; Humans; Infant; Lipase; Pancr | 1991 |
Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis.
Topics: 4-Aminobenzoic Acid; Adult; Age Factors; Amylases; Blood Glucose; Cystic Fibrosis; Female; Glucose T | 1990 |
Non-invasive assessment of intraluminal lipolysis using a 13CO2 breath test.
Topics: Breath Tests; Caprylates; Carbon Dioxide; Carbon Isotopes; Child; Child, Preschool; Cystic Fibrosis; | 1990 |
Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity.
Topics: Adult; Capsules; Child; Cystic Fibrosis; Female; Humans; Infant; Lipase; Male; Pancreatic Extracts; | 1990 |
Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function.
Topics: Amylases; Animals; Body Weight; Cystic Fibrosis; Disease Models, Animal; Eating; Lipase; Male; Nutri | 1986 |
Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosis.
Topics: Animals; Cystic Fibrosis; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Enzyme P | 1989 |
Effect of pancreatic enzyme supplements on iron absorption.
Topics: Adolescent; Adult; Cystic Fibrosis; Female; Ferritins; Humans; Iron; Iron Deficiencies; Lipase; Male | 1989 |
Uric acid serum concentrations in CF-children after pancreatic enzyme supplementation.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Humans; Lipase; Male; Uric Acid | 1989 |
Alginate lyase releases cell-bound lipase from mucoid strains of Pseudomonas aeruginosa.
Topics: Bacillus; Chromatography, Gel; Chromatography, Ion Exchange; Cystic Fibrosis; Electrophoresis, Polya | 1987 |
Human gastric lipase: variations induced by gastrointestinal hormones and by pathology.
Topics: Adolescent; Adult; Aged; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Gastric Mucosa; | 1988 |
Production of lipase by clinical isolates of Pseudomonas cepacia.
Topics: Animals; Chromatography, Gel; Culture Media; Cystic Fibrosis; Electrophoresis, Polyacrylamide Gel; F | 1988 |
The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
Topics: Adolescent; Body Weight; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Fem | 1988 |
Malabsorption in cystic fibrosis: mechanisms and treatment.
Topics: Acetylcysteine; Adolescent; Celiac Disease; Child; Cystic Fibrosis; Drug Administration Schedule; Dr | 1988 |
Pancreatic and intestinal dysfunction in cystic fibrosis.
Topics: Biological Transport, Active; Cystic Fibrosis; Humans; Intestinal Absorption; Lipase; Pancreas; Panc | 1987 |
[Activity of various pancreatic enzymes in children with mucoviscidosis].
Topics: Adolescent; alpha 1-Antitrypsin; Child; Child, Preschool; Cystic Fibrosis; Humans; Lipase; Pancreas; | 1987 |
Assay of human pancreatic lipase in biological fluids using a non-competitive enzyme immunoassay.
Topics: Amniotic Fluid; Body Fluids; Cystic Fibrosis; Humans; Immunoenzyme Techniques; Lipase; Lipid Metabol | 1986 |
Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Child; Cystic Fibrosis; Duodenum; Female; Food; Humans; Hy | 1987 |
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption.
Topics: Adolescent; Adult; Bile Acids and Salts; Celiac Disease; Colipases; Cystic Fibrosis; Exocrine Pancre | 1986 |
Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening.
Topics: Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Lipase; Male; Mass Screening; Pancreatic E | 1985 |
Problems in the treatment of malabsorption in CF.
Topics: Bicarbonates; Bile Acids and Salts; Child; Cystic Fibrosis; Dietary Fats; Enzyme Therapy; Enzymes; G | 1985 |
Enzyme immunoassay for pancreatic lipase: comparison with turbidimetric method in pancreatic diseases.
Topics: Acute Disease; Adult; Aged; Child, Preschool; Chronic Disease; Clinical Enzyme Tests; Cystic Fibrosi | 1985 |
Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Topics: Adolescent; Adult; Cations; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; | 1986 |
Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis.
Topics: Age Factors; Child; Child, Preschool; Cystic Fibrosis; Fetal Blood; Humans; Infant; Infant, Newborn; | 1985 |
Pancreatic lipase and phospholipase A2 concentration in amniotic fluid and the prenatal diagnosis of cystic fibrosis.
Topics: Amniotic Fluid; Cystic Fibrosis; Female; Humans; Lipase; Pancreas; Phospholipases; Phospholipases A; | 1985 |
Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; | 1985 |
[Activity of lipolytic enzymes in the sputum, duodenal juice and serum of children with mucoviscidosis].
Topics: Age Factors; Child; Cystic Fibrosis; Duodenum; Humans; Intestinal Secretions; Lipase; Phospholipases | 1974 |
Mucoid enteritis of rabbits. Comparison to cholera and cystic fibrosis.
Topics: Animals; Blood Glucose; Blood Proteins; Cecum; Cholera; Colon; Cystic Fibrosis; Enteritis; Female; H | 1972 |
L-arginine and cystic fibrosis.
Topics: Adolescent; Amylases; Arginine; Child; Cystic Fibrosis; Humans; Lipase; Pancreas; Trypsin | 1973 |
Malabsorption of bile acids in children with cystic fibrosis.
Topics: Adolescent; Bile Acids and Salts; Celiac Disease; Child; Child, Preschool; Chromatography, Gas; Cyst | 1973 |
[Exocrine pancreatic secretion in children. Study methods and results].
Topics: Amylases; Bicarbonates; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Ne | 1973 |
Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.
Topics: Adolescent; Adult; Body Height; Body Weight; Carboxypeptidases; Carotenoids; Celiac Disease; Child; | 1974 |
Insulin secretion after tolbutamide and after secretin in patients with pancreatic diseases.
Topics: Adolescent; Adult; Aged; Amylases; Blood Glucose; Calcinosis; Cystic Fibrosis; Duodenum; Feces; Fema | 1972 |
[Hereditary abnormalities of digestive enzymes].
Topics: Cystic Fibrosis; Endopeptidases; Humans; Lipase; Malabsorption Syndromes; Metabolism, Inborn Errors; | 1971 |
[Study of exocrine pancreatic function in mucoviscidosis].
Topics: Adolescent; Amylases; Bicarbonates; Child; Child, Preschool; Cholecystokinin; Chymotrypsin; Cystic F | 1969 |
Pancreatic extracts.
Topics: Adult; Aged; Bicarbonates; Bile Acids and Salts; Cystic Fibrosis; Humans; Infant; Lipase; Malabsorpt | 1970 |
Kinetics of fat hydrolysis and micellar solubilisation in bile and lipase deficiencies.
Topics: Bile; Bile Acids and Salts; Biliary Tract Diseases; Child, Preschool; Cystic Fibrosis; Fatty Acids, | 1971 |
Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease.
Topics: Adolescent; Adult; Amylases; Bicarbonates; Carboxypeptidases; Child; Child, Preschool; Chlorides; Ch | 1968 |
[Hypoplasia of exocrine pancreas. Associated myoendocardial fibrosis in 1 of 2 brothers].
Topics: Amylases; Chymotrypsin; Cystic Fibrosis; Endomyocardial Fibrosis; Humans; Infant; Infant, Newborn; L | 1969 |
[Serum lipase in pancreatic diagnosis. Clinical experiences based on 498 determinations].
Topics: Adult; Bile Duct Neoplasms; Clinical Enzyme Tests; Cystic Fibrosis; Female; Humans; Lipase; Male; Me | 1966 |
Cystic fibrosis--V. Does cystic fibrosis alter the values of dynamic parameters of erythrocyte membrane ghosts?
Topics: Anilino Naphthalenesulfonates; Child; Child, Preschool; Cystic Fibrosis; Diphenylhexatriene; Electro | 1993 |